华森制药：2025年半年度净利润约5395万元，同比增加14.27%

Core Viewpoint - Huason Pharmaceutical reported a year-on-year increase in revenue and net profit for the first half of 2025, indicating positive growth trends in its financial performance [2]. Financial Performance - The company's revenue for the first half of 2025 was approximately 442 million yuan, representing a year-on-year increase of 5.76% [2]. - The net profit attributable to shareholders was around 53.95 million yuan, showing a year-on-year increase of 14.27% [2]. - Basic earnings per share were 0.1292 yuan, which is a year-on-year increase of 14.24% [2].